Table 1.
Baseline Characteristics
| Characteristic | Calcium acetate (N = 46) |
Placebo (N = 64) |
P-value |
|---|---|---|---|
| Age (years) | 63.2 ± 11.7 | 62.2 ± 14.2 | 0.69 |
| Gender (female) | 23 (50%) | 29 (45.3%) | 0.63 |
| Race (white) | 33 (71.7%) | 54 (84.4%) | 0.34 |
| Diabetes | 31 (67.4%) | 49 (76.6%) | 0.29 |
| Weight (Kg) | 82.9 ± 23.2 | 80.8 ± 25.6 | 0.65 |
| Serum phosphorus (mg/dL) | 5.1 ± 1.2 | 5.1 ± 1.1 | 0.76 |
| Serum calcium, corrected (mg/dL) | 9.1 ± 0.7 | 9.1 ± 0.6 | 0.97 |
| Intact parathyroid hormone (pg/mL)1 | 253 ± 213 | 322 ± 267 | 0.16 |
| Serum albumin (mg/dL) | 3.6 ± 0.5 | 3.5 ± 0.5 | 0.56 |
| Serum bicarbonate (mEq/L) | 22.6 ± 3.9 | 21.9 ± 3.7 | 0.33 |
| Estimated glomerular filtration rate (mL/min/1.73 m2) | 17.3 ± 5.6 | 16.4 ± 6.2 | 0.43 |
1Available in 45 and 56 patients in the calcium acetate and placebo groups, respectively.